T1	Participants 136 168	Radiation Therapy Oncology Group
T2	Participants 854 885	Patients were randomly assigned
T3	Participants 1178 1205	patients treated with PO RT
T4	Participants 1217 1233	Patients treated
T5	Participants 1641 1670	in patients with a risk of LN
